You just read:

Rigel to Present One-Year Efficacy and Safety Results for Fostamatinib in ITP at the 2017 American Society of Hematology Annual Meeting

News provided by

Rigel Pharmaceuticals, Inc.

Dec 08, 2017, 06:30 EST